SCHEMBL21436367

SCHEMBL21436367

Nc1c(C(F)(F)F)[c]ccc1F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL585620 0.77
SCHEMBL19133532 0.76
SCHEMBL16049653 0.72
SCHEMBL81364 0.68
SCHEMBL5314612 0.68 CYP3A4 (0.41)
SCHEMBL11573442 0.68 ALOX15 (0.34)
SCHEMBL760452 0.67
SCHEMBL5918349 0.66 TRPA1 (0.38)
SCHEMBL6986496 0.65 KDM4E (0.37)
SCHEMBL1509972 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107922338-A The pyridine and application method being substituted 艾伯维公司 2018-04-17 CN claimed
WO-2019193062-A1 SUBSTITUTED PYRROLIDINES AND THEIR USE ABBVIE S.Á.R.L (LU) 2019-10-10 WO disclosed
CN-110036009-A Substituted pyrrolidines and their use in the treatment of cystic fibrosis 艾伯维公司 2019-07-19 CN disclosed
CN-110035993-A SUBSTITUTED PYRROLIDINES AS CFTR MODULATORS 艾伯维公司 2019-07-19 CN disclosed
CN-109311864-A Heteroaryl substituted pyridines and methods of use 艾伯维公司 2019-02-05 CN disclosed
CN-109219602-A Modulators of cystic fibrosis transmembrane conductance regulator proteins 艾伯维公司 2019-01-15 CN disclosed
CN-107922338-A The pyridine and application method being substituted 艾伯维公司 2018-04-17 CN disclosed